In its proposed fiscal year 2016 funding bill, the House Appropriations Committee is looking to defund the Affordable Care Act, block additional funding for patient-centered outcomes research, and terminate the Agency for Healthcare Research and Quality.
In its proposed fiscal year 2016 funding bill, the House Appropriations Committee is looking to defund the Affordable Care Act, block additional funding for patient-centered outcomes research, and terminate the Agency for Healthcare Research and Quality.
The draft bill reduces discretionary funding by $3.7 billion from fiscal year 2015 and is $14.6 billion below President Obama’s budget request.
“This legislation continues our efforts to reduce wasteful spending, to stop harmful and unnecessary regulations that kill jobs and impede economic growth, and to make wise investments in proven programs on behalf of the American taxpayer,” House Appropriations Chairman Hal Rogers said in a statement.
The bill rescinds $6.8 billion in funding for the Center for Medicare and Medicaid Innovation, and $100 million for the Patient-Centered Outcomes Research Trust, and will transfer $914.3 million from the Prevention and Public Health Fund to the Centers for Disease Control and Prevention.
However, under the draft bill, the National Institutes of Health would receive $31.2 billion, which is $1.1 billion above funding for fiscal year 2015.
Read more at Inside Health Policy: http://bit.ly/1CdZ8ZA
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More